IceCure Medical (ICCM) Liabilities and Shareholders Equity (2020 - 2026)

IceCure Medical (ICCM) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $13.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 19.8% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $52.9 million (down 2.69% YoY), while the FY2025 annual figure was $13.9 million, up 10.43% from the prior year.
• Liabilities and Shareholders Equity retreated to $13.3 million in Q1 2026 per ICCM's latest filing, from $13.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $30.2 million in Q4 2022 and bottomed at $10.6 million in Q2 2025.
• Historically, Liabilities and Shareholders Equity has averaged $18.3 million across 5 years, with a median of $16.1 million in 2024.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity sank 45.64% — and 2026, when it advanced 19.8%.
• IceCure Medical's Liabilities and Shareholders Equity stood at $30.2 million in 2022, then slumped by 45.64% to $16.4 million in 2023, then fell by 23.36% to $12.6 million in 2024, then climbed by 10.43% to $13.9 million in 2025, then fell by 4.21% to $13.3 million in 2026.
• Business Quant data shows ICCM's Liabilities and Shareholders Equity at $13.3 million in Q1 2026, $13.9 million in Q4 2025, and $15.1 million in Q3 2025.